At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 2,500 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NCT04689802N/ARecruitingUpdate OverdueUpdated 13mo ago · Completion was 6mo agoEnrollment Stalled
Long Recruiting
Update Overdue
To Identify Potential New Urine Marker Panel for Cancer Screening
In Brief
An observational study for Cancer. Currently recruiting, targeting 2,500 participants across 1 site.
Signals
Enrollment appears stalled
Detailed Summary
Polyamines are naturally produced metabolites in our cells. There were some reports suggested the urinary levels of polyamines were altered in patients with different cancers. This study is to explore the use of urinary polyamine for the diagnosis of common cancers.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCancer
CountriesHong Kong
Collaborators--
Timeline
N/ARecruitingOverdue
202120222023202420252026
First PostedDec 2020
Enrollment StartJan 2021
Primary CompletionDec 2025
Study CompletionMar 2026
TodayJul 2026
First PostedDec 30, 2020
Enrollment StartJan 20, 2021
Primary CompletionDec 31, 2025
Study CompletionMar 31, 2026
TodayJul 1, 2026
Enrollment to primary: 4.9 yearsPosted 5.5 years ago